EDGAR Filing Documents for 0001683168-22-000418

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001683168-22-000418

Filing Date

2022-01-24

Accepted

2022-01-24 16:24:19

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT TO FORM S-1	sunshine_s1a1.htm iXBRL	S-1/A	1277342
2	SPONSORED RESEARCH AGREEMENT	sunshine_ex1007.htm	EX-10.7	144777
3	CONSENT	sunshine_ex2301.htm	EX-23.1	1867
9	GRAPHIC	image_001.jpg	GRAPHIC	7392
10	GRAPHIC	image_007.jpg	GRAPHIC	11849
11	GRAPHIC	image_008.jpg	GRAPHIC	13466
12	GRAPHIC	image_009.jpg	GRAPHIC	18576
13	GRAPHIC	image_010.jpg	GRAPHIC	9687
14	GRAPHIC	image_003.jpg	GRAPHIC	6733
	Complete submission text file	0001683168-22-000418.txt		3678119

Data Files

Seq	Description	Document	Type	Size
4	XBRL SCHEMA FILE	sbfm-20210930.xsd	EX-101.SCH	15405
5	XBRL CALCULATION FILE	sbfm-20210930_cal.xml	EX-101.CAL	34965
6	XBRL DEFINITION FILE	sbfm-20210930_def.xml	EX-101.DEF	77106
7	XBRL LABEL FILE	sbfm-20210930_lab.xml	EX-101.LAB	160040
8	XBRL PRESENTATION FILE	sbfm-20210930_pre.xml	EX-101.PRE	130705
33	EXTRACTED XBRL INSTANCE DOCUMENT	sunshine_s1a1_htm.xml	XML	224416

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5

Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)